ACH
ACCENDRA HEALTH INC/VA/
-0.02 (-1.87%)1.05USD168K成交股數80.7M市值–本益比(近四季)0.0股價營收比-10.1%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 613M-10% | 628M-7% | 709M+3% | 697M+6% | 682M-74% | 674M-113% | 687M-73% | 660M-74% | 2.6B | −5.1B | 2.6B | 2.6B |
| 營業成本 | 350M | 350M | 386M | 375M | 357M | 355M | 355M | 344M | 2.1B | −4.8B | 2.1B | 2.0B |
| 毛利 | 263M-19% | 278M-47% | 116M-79% | 322M-41% | 325M-39% | 526M-8% | 560M+4% | 544M+5% | 536M | 570M | 538M | 519M |
| 毛利率 | 43.0% | 44.3% | 16.4% | 46.2% | 47.6% | 78.1% | 81.5% | 82.4% | 20.5% | -11.1% | 20.8% | 20.3% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 244M | 255M | 271M | 266M | 268M | 262M | 272M | 270M | 478M | −355M | 453M | 455M |
| 營業利益 | −35.2M-11% | 17.1M-13% | 20.9M-33% | 26.5M+56% | −39.7M-510% | 19.8M-78% | 31.1M+30% | 16.9M+56% | 9.7M | 88.7M | 23.8M | 10.8M |
| 營業利益率 | -5.7% | 2.7% | 2.9% | 3.8% | -5.8% | 2.9% | 4.5% | 2.6% | 0.4% | -1.7% | 0.9% | 0.4% |
| 稅後淨利 | −89.1M-90% | −6.5M-74% | −56.3M+341% | −150M+371% | −869M+3871% | −25.0M-240% | −12.8M+99% | −31.9M+13% | −21.9M | 17.8M | −6.4M | −28.2M |
| 淨利率 | -14.5% | -1.0% | -7.9% | -21.6% | -127.4% | -3.7% | -1.9% | -4.8% | -0.8% | -0.3% | -0.2% | -1.1% |
| 稀釋 EPS | -1.16-90% | -0.08-75% | -0.75+369% | -1.94+362% | -11.30+3797% | -0.32-233% | -0.16+100% | -0.42+14% | -0.29 | 0.24 | -0.08 | -0.37 |
| 稀釋股數 | 76.7M | 76.4M | 76.9M | 77.3M | 76.9M | 77.3M | 78.5M | 76.7M | 76.3M | 77.4M | 76.2M | 75.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.7M | 337M | 282M | 32.8M | 38.3M | 59.4M | 45.5M | 244M | 245M | 243M | 215M | 286M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 73.3M | 65.3M | 74.4M | 63.8M | 69.2M | 1.4B | 1.2B | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B |
| 總資產 | 2.1B | 2.4B | 2.5B | 4.0B | 4.2B | 4.9B | 5.1B | 5.3B | 5.2B | 5.1B | 5.1B | 5.3B |
| 有息負債 | 1.7B | 1.5B | 1.8B | 1.8B | 1.6B | 1.9B | 1.8B | 1.9B | 1.9B | 1.9B | 2.1B | 2.3B |
| 總負債 | 2.7B | 2.9B | 2.9B | 4.5B | 4.4B | 4.3B | 4.2B | 4.4B | 4.3B | 4.2B | 4.2B | 4.4B |
| 股東權益 | −551M | −465M | −461M | −430M | −281M | 571M | 896M | 882M | 916M | 945M | 887M | 896M |
| 負債比 | 126.1% | 119.2% | 118.8% | 110.6% | 106.8% | 88.2% | 82.8% | 83.8% | 82.8% | 81.9% | 82.7% | 83.1% |
| 淨現金(現金 − 有息負債) | −1.7B | −1.2B | −1.5B | −1.8B | −1.6B | −1.8B | −1.8B | −1.6B | −1.7B | −1.6B | −1.9B | −2.0B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −50.1M+43% | – | – | – | −35.1M | – | – | −53.0M | – | – | – |
| 資本支出 | – | 41.6M | – | – | – | 45.8M | 61.5M | 45.8M | 46.0M | 26.1M | 50.6M | 49.5M |
| 自由現金流 | – | −91.7M+13% | – | – | – | −80.9M | – | – | −99.0M | – | – | – |
| 折舊攤銷 | – | 61.7M | – | – | – | 42.9M | 61.6M | 63.9M | 74.1M | −6.3M | 73.7M | 72.1M |
| 買回庫藏股 | – | 0.00 | – | – | – | 1.5M | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -14.6% | – | – | – | -12.0% | – | – | -3.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
主要客戶2025 年度 · 2.8B
| Commercial Payors | 2.2B | 80.6% | +2.2% |
|---|---|---|---|
| Medicare | 498M | 18.0% | +7.8% |
| Medicaid | 38.5M | 1.4% | -4.3% |
產品／服務2025 年度 · 2.0B
| Diabetes Product | 783M | 38.7% | +0.8% |
|---|---|---|---|
| Home Respiratory Therapy Product | 433M | 21.4% | -0.7% |
| Product And Service Other | 288M | 14.3% | +7.4% |
| Ostomy | 213M | 10.5% | +8.6% |
| Wound Care | 189M | 9.3% | -2.0% |
| Urology | 116M | 5.7% | +8.3% |
| Sleep Therapy Product 小計 | 740M | 36.6% | +5.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.8B | +3.1% | −1.1B | -39.8% | -14.31 | −293M |
| FY2024 | 2.7B | +5.0% | −363M | -13.5% | -4.73 | −8.8M |
| FY2023 | 2.6B | -74.4% | −41.3M | -1.6% | -0.53 | 568M |
| FY2022 | 10.0B | +1.7% | 22.4M | 0.2% | 0.29 | 167M |
| FY2021 | 9.8B | +15.4% | 222M | 2.3% | 2.94 | 83.2M |
| FY2020 | 8.5B | -7.9% | 29.9M | 0.4% | 0.47 | 289M |
| FY2019 | 9.2B | -2.2% | −62.4M | -0.7% | -1.03 | 124M |
| FY2018 | 9.4B | – | −437M | -4.6% | -7.28 | 70.7M |